Comparative analysis of surgical techniques in the management of chronic subdural hematomas and risk factors for poor outcomes.


Journal

Neurosurgical review
ISSN: 1437-2320
Titre abrégé: Neurosurg Rev
Pays: Germany
ID NLM: 7908181

Informations de publication

Date de publication:
03 Jun 2024
Historique:
received: 19 11 2023
accepted: 25 05 2024
revised: 29 04 2024
medline: 3 6 2024
pubmed: 3 6 2024
entrez: 3 6 2024
Statut: epublish

Résumé

Chronic subdural hematomas (CSDH) are increasingly prevalent, especially among the elderly. Surgical intervention is essential in most cases. However, the choice of surgical technique, either craniotomy or burr-hole opening, remains a subject of debate. Additionally, the risk factors for poor long-term outcomes following surgical treatment remain poorly described. This article presents a 10-year retrospective cohort study conducted at a single center that aimed to compare the outcomes of two common surgical techniques for CSDH evacuation: burr hole opening and minicraniotomy. The study also identified risk factors associated with poor long-term outcome, which was defined as an mRS score ≥ 3 at 6 months. This study included 582 adult patients who were surgically treated for unilateral CSDH. Burr-hole opening was performed in 43% of the patients, while minicraniotomy was performed in 57%. Recurrence was observed in 10% of the cases and postoperative complications in 13%. The rates of recurrence, postoperative complications, death and poor long-term outcome did not differ significantly between the two surgical approaches. Multivariate analysis identified postoperative general complications, recurrence, and preoperative mRS score ≥ 3 as independent risk factors for poor outcomes at 6 months. Recurrence contribute to a poorer prognosis in CSDH. Nevertheless, use burr hole or minicraniotomy for the management of CSDH showed a similar recurrence rate and no significant differences in post-operative outcomes. This underlines the need for a thorough assessment of patients with CSHD and the importance of avoiding their occurrence, by promoting early mobilization of patients. Future research is necessary to mitigate the risk of recurrence, regardless of the surgical technique employed.

Identifiants

pubmed: 38829539
doi: 10.1007/s10143-024-02493-y
pii: 10.1007/s10143-024-02493-y
doi:

Types de publication

Journal Article Comparative Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

254

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Abecassis IJ, Kim LJ (2017) Craniotomy for treatment of chronic subdural hematoma. Neurosurg Clin N Am 28:229–237. https://doi.org/10.1016/j.nec.2016.11.005
doi: 10.1016/j.nec.2016.11.005 pubmed: 28325457
Almenawer SA, Farrokhyar F, Hong C, Alhazzani W, Manoranjan B, Yarascavitch B, Arjmand P, Baronia B, Reddy K, Murty N, Singh S (2014) Chronic subdural hematoma management: a systematic review and meta-analysis of 34,829 patients. Ann Surg 259:449–457. https://doi.org/10.1097/SLA.0000000000000255
doi: 10.1097/SLA.0000000000000255 pubmed: 24096761
Amano T, Miyamatsu Y, Otsuji R, Nakamizo A (2021) Efficacy of endoscopic treatment for chronic subdural hematoma surgery. J Clin Neurosci 92:78–84. https://doi.org/10.1016/j.jocn.2021.07.058
doi: 10.1016/j.jocn.2021.07.058 pubmed: 34509267
Aspegren OP, Åstrand R, Lundgren MI, Romner B (2013) Anticoagulation therapy a risk factor for the development of chronic subdural hematoma. Clin Neurol Neurosurg 115:981–984. https://doi.org/10.1016/j.clineuro.2012.10.008
doi: 10.1016/j.clineuro.2012.10.008 pubmed: 23128014
Chen JC, Levy ML (2000) Causes, epidemiology, and risk factors of chronic subdural hematoma. Neurosurg Clin N Am 11:399–406
doi: 10.1016/S1042-3680(18)30101-3 pubmed: 10918008
Ducruet AF, Grobelny BT, Zacharia BE, Hickman ZL, DeRosa PL, Andersen KN, Sussman E, Carpenter A, Connolly ES (2012) The surgical management of chronic subdural hematoma. Neurosurg Rev 35:155–169 discussion 169. https://doi.org/10.1007/s10143-011-0349-y
doi: 10.1007/s10143-011-0349-y pubmed: 21909694
Duerinck J, Van Der Veken J, Schuind S, Van Calenbergh F, van Loon J, Du Four S, Debacker S, Costa E, Raftopoulos C, De Witte O, Cools W, Buyl R, Van Velthoven V, D’Haens J, Bruneau M (2022) Randomized trial comparing Burr Hole Craniostomy, Minicraniotomy, and twist Drill craniostomy for treatment of chronic subdural hematoma. Neurosurgery 91:304–311. https://doi.org/10.1227/neu.0000000000001997
doi: 10.1227/neu.0000000000001997 pubmed: 35593710
Edlmann E, Giorgi-Coll S, Whitfield PC, Carpenter KLH, Hutchinson PJ (2017) Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy. J Neuroinflammation 14:108. https://doi.org/10.1186/s12974-017-0881-y
doi: 10.1186/s12974-017-0881-y pubmed: 28558815 pmcid: 5450087
Feghali J, Yang W, Huang J (2020) Updates in chronic subdural hematoma: epidemiology, etiology, Pathogenesis, treatment, and Outcome. World Neurosurg 141:339–345. https://doi.org/10.1016/j.wneu.2020.06.140
doi: 10.1016/j.wneu.2020.06.140 pubmed: 32593768
Gonugunta V, Buxton N (2001) Warfarin and chronic subdural haematomas. Br J Neurosurg 15:514–517. https://doi.org/10.1080/02688690120097822
doi: 10.1080/02688690120097822 pubmed: 11814005
Haseeb A, Shafique MA, Kumar A, Raqib MA, Mughal ZUN, Nasir R, Sinaan Ali SM, Ahmad TKF, Mustafa MS (2023) Efficacy and safety of steroids for chronic subdural hematoma: a systematic review and meta-analysis. Surg Neurol Int 14:449. https://doi.org/10.25259/SNI_771_2023
doi: 10.25259/SNI_771_2023 pubmed: 38213424 pmcid: 10783700
Hutchinson PJ, Edlmann E, Bulters D, Zolnourian A, Holton P, Suttner N, Agyemang K, Thomson S, Anderson IA, Al-Tamimi YZ, Henderson D, Whitfield PC, Gherle M, Brennan PM, Allison A, Thelin EP, Tarantino S, Pantaleo B, Caldwell K, Davis-Wilkie C, Mee H, Warburton EA, Barton G, Chari A, Marcus HJ, King AT, Belli A, Myint PK, Wilkinson I, Santarius T, Turner C, Bond S, Kolias AG (2020) Trial of Dexamethasone for Chronic Subdural Hematoma. N Engl J Med 383:2616–2627. https://doi.org/10.1056/NEJMoa2020473 . British Neurosurgical Trainee Research Collaborative, Dex-CSDH Trial Collaborators
doi: 10.1056/NEJMoa2020473 pubmed: 33326713
Ivamoto HS, Lemos HP, Atallah AN (2016) Surgical treatments for chronic subdural hematomas: a comprehensive systematic review. World Neurosurg 86:399–418. https://doi.org/10.1016/j.wneu.2015.10.025
doi: 10.1016/j.wneu.2015.10.025 pubmed: 26485412
Kinoshita S, Ohkuma H, Fujiwara N, Katayama K, Naraoka M, Shimamura N, Tabata H, Takemura A, Hasegawa S, Saito A (2024) Long-term postoperative prognosis and associated risk factors of chronic subdural hematoma in the elderly. Clin Neurol Neurosurg 108186. https://doi.org/10.1016/j.clineuro.2024.108186
Kolias AG, Chari A, Santarius T, Hutchinson PJ (2014) Chronic subdural haematoma: modern management and emerging therapies. Nat Rev Neurol 10:570–578. https://doi.org/10.1038/nrneurol.2014.163
doi: 10.1038/nrneurol.2014.163 pubmed: 25224156
Kurabe S, Ozawa T, Watanabe T, Aiba T (2010) Efficacy and safety of postoperative early mobilization for chronic subdural hematoma in elderly patients. Acta Neurochir (Wien) 152:1171–1174. https://doi.org/10.1007/s00701-010-0627-4
doi: 10.1007/s00701-010-0627-4 pubmed: 20336332
Lega BC, Danish SF, Malhotra NR, Sonnad SS, Stein SC (2010) Choosing the best operation for chronic subdural hematoma: a decision analysis. J Neurosurg 113:615–621. https://doi.org/10.3171/2009.9.JNS08825
doi: 10.3171/2009.9.JNS08825 pubmed: 19877806
Liu W, Bakker NA, Groen RJM (2014) Chronic subdural hematoma: a systematic review and meta-analysis of surgical procedures. J Neurosurg 121:665–673. https://doi.org/10.3171/2014.5.JNS132715
doi: 10.3171/2014.5.JNS132715 pubmed: 24995782
Maldaner N, Sosnova M, Sarnthein J, Bozinov O, Regli L, Stienen MN (2018) Burr hole trepanation for chronic subdural hematomas: is surgical education safe? Acta Neurochir (Wien) 160:901–911. https://doi.org/10.1007/s00701-017-3458-8
doi: 10.1007/s00701-017-3458-8 pubmed: 29313100
Mehta V, Harward SC, Sankey EW, Nayar G, Codd PJ (2018) Evidence based diagnosis and management of chronic subdural hematoma: a review of the literature. J Clin Neurosci 50:7–15. https://doi.org/10.1016/j.jocn.2018.01.050
doi: 10.1016/j.jocn.2018.01.050 pubmed: 29428263
Nakajima H, Yasui T, Nishikawa M, Kishi H, Kan M (2002) The role of postoperative patient posture in the recurrence of chronic subdural hematoma: a prospective randomized trial. Surg Neurol 58:385–387 discussion 387. https://doi.org/10.1016/s0090-3019(02)00921-7
doi: 10.1016/s0090-3019(02)00921-7 pubmed: 12517615
Santarius T, Kirkpatrick PJ, Kolias AG, Hutchinson PJ (2010) Working toward rational and evidence-based treatment of chronic subdural hematoma. Clin Neurosurg 57:112–122
pubmed: 21280503
Schucht P, Fischer U, Fung C, Bernasconi C, Fichtner J, Vulcu S, Schöni D, Nowacki A, Wanderer S, Eisenring C, Krähenbühl AK, Mattle HP, Arnold M, Söll N, Tochtermann L, Z’Graggen W, Jünger ST, Gralla J, Mordasini P, Dahlweid FM, Raabe A, Beck J (2019) Follow-up computed tomography after evacuation of chronic subdural hematoma. N Engl J Med 380:1186–1187. https://doi.org/10.1056/NEJMc1812507
doi: 10.1056/NEJMc1812507 pubmed: 30893542
Shrestha DB, Budhathoki P, Sedhai YR, Jain S, Karki P, Jha P, Mainali G, Ghimire P (2022) Steroid in chronic subdural hematoma: an updated systematic review and Meta-analysis Post DEX-CSDH Trial. World Neurosurg 158:84–99. https://doi.org/10.1016/j.wneu.2021.10.167
doi: 10.1016/j.wneu.2021.10.167 pubmed: 34728401
Tazreean R, Nelson G, Twomey R (2022) Early mobilization in enhanced recovery after surgery pathways: current evidence and recent advancements. J Comp Eff Res 11:121–129. https://doi.org/10.2217/cer-2021-0258
doi: 10.2217/cer-2021-0258 pubmed: 35045757
Torihashi K, Sadamasa N, Yoshida K, Narumi O, Chin M, Yamagata S (2008) Independent predictors for recurrence of chronic subdural hematoma: a review of 343 consecutive surgical cases. Neurosurgery 63:1125–1129 discussion 1129. https://doi.org/10.1227/01.NEU.0000335782.60059.17
doi: 10.1227/01.NEU.0000335782.60059.17 pubmed: 19008766
Weigel R, Schmiedek P, Krauss JK (2003) Outcome of contemporary surgery for chronic subdural haematoma: evidence based review. J Neurol Neurosurg Psychiatry 74:937–943. https://doi.org/10.1136/jnnp.74.7.937
doi: 10.1136/jnnp.74.7.937 pubmed: 12810784 pmcid: 1738576
Wu L, Guo X, Ou Y, Yu X, Zhu B, Yang C, Liu W (2023) Efficacy analysis of neuroendoscopy-assisted burr-hole evacuation for chronic subdural hematoma: a systematic review and meta-analysis. Neurosurg Rev 46:98. https://doi.org/10.1007/s10143-023-02007-2
doi: 10.1007/s10143-023-02007-2 pubmed: 37115314
Yang W, Huang J (2017) Chronic subdural hematoma: epidemiology and natural history. Neurosurg Clin N Am 28:205–210. https://doi.org/10.1016/j.nec.2016.11.002
doi: 10.1016/j.nec.2016.11.002 pubmed: 28325454

Auteurs

Stachys Hounkpatin (S)

Caen University Hospital, Department of Neurosurgery, Caen, France.
Niamey University Hospital, Department of Neurosurgery, Niamey, Niger.
Caen Normandy University, Caen, France.

Marine Stierer (M)

Caen Normandy University, Caen, France.

Paul Frechon (P)

Caen University Hospital, Department of Neurosurgery, Caen, France.
Caen Normandy University, Caen, France.

Frederick Rault (F)

Caen University Hospital, Department of Neurosurgery, Caen, France.

Aminath Kelani (A)

Niamey University Hospital, Department of Neurosurgery, Niamey, Niger.
Abdou Moumouni University, Niamey, Niger.

Evelyne Emery (E)

Caen University Hospital, Department of Neurosurgery, Caen, France.
Caen Normandie University, INSERM, U1237, PhIND Physiopathology and Imaging of Neurological Disorders, Institut Blood and Brain @ Caen-Normandie, GIP Cyceron, Caen, France.

Thomas Gaberel (T)

Caen University Hospital, Department of Neurosurgery, Caen, France.
Caen Normandie University, INSERM, U1237, PhIND Physiopathology and Imaging of Neurological Disorders, Institut Blood and Brain @ Caen-Normandie, GIP Cyceron, Caen, France.

Arthur Leclerc (A)

Caen University Hospital, Department of Neurosurgery, Caen, France. arthur.leclerc@neurochirurgie.fr.
Caen Normandie University, ISTCT UMR6030, GIP Cyceron, Caen, France. arthur.leclerc@neurochirurgie.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH